Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001799191-25-000017

Chief Executive Officer acquired 1,083,334 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Virnich Daniel · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2025-03-31 Grant or award : show line 1 in the form +1,083,334 1,807,697 D
Loading xslF345X05/wk-form4_1743628144.xml…